MGMT and glioblastoma: (26) demonstrated that lomustine exhibits synergistic cytotoxic effects in MGMT promoter methylated glioblastoma cells, independent of MGMT status, suggesting a potential enhancement of treatment efficacy when used in conjunction with TMZ.